F I Ershov Selected Research

F I Ershov Research Topics

Disease

12	Human Influenza (Influenza) 01/2021 - 09/2000
11	Infections 01/2021 - 01/2000
10	Virus Diseases (Viral Diseases) 01/2021 - 05/2000
3	Hepatitis 01/2015 - 01/2001
3	Tuberculosis (Tuberculoses) 01/2014 - 01/2013
3	Communicable Diseases (Infectious Diseases) 01/2008 - 05/2000
2	COVID-19 01/2022 - 01/2021
2	Coronavirus Infections 01/2022 - 01/2021
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 01/2019
2	Neoplasms (Cancer) 01/2016 - 01/2004
2	Herpes Genitalis (Genital Herpes) 01/2015 - 11/2003
2	Brucellosis (Malta Fever) 01/2014 - 01/2013
2	HIV Infections (HIV Infection) 01/2013 - 01/2001
2	Chronic Hepatitis C 01/2013 - 01/2013
2	Pyelonephritis 01/2011 - 01/2010
2	Herpetic Keratitis 01/2001 - 01/2000
1	Viral Pneumonia 01/2021
1	Fever (Fevers) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2020
1	Keratoconjunctivitis 01/2019
1	Eye Infections 01/2019
1	Coinfection 01/2015
1	Encephalitis (Encephalitis, Rasmussen) 01/2015
1	Herpes Simplex 01/2015
1	Rabies (Hydrophobia) 01/2015
1	West Nile Fever 01/2013
1	Viremia 01/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2013
1	Chronic Disease (Chronic Diseases) 01/2013
1	Pathologic Processes 01/2011
1	Kidney Diseases (Kidney Disease) 01/2010
1	Disease Progression 01/2010
1	Rheumatic Diseases (Rheumatism) 01/2010
1	Neurasthenia 01/2008
1	Anxiety Disorders (Anxiety Disorder) 01/2008
1	Leukoplakia 12/2004
1	Leukemia 01/2004
1	Hepatitis C 01/2002
1	Multiple Sclerosis 04/2001
1	Hepatitis A (Hepatitis, Infectious) 02/2001
1	Hepatitis B 02/2001
1	Viral Encephalitis 02/2001
1	Inflammation (Inflammations) 01/2000
1	Conjunctivitis 01/2000

Drug/Important Bio-Agent (IBA)

14	InterferonsIBA 01/2022 - 01/2000
8	CytokinesIBA 01/2019 - 01/2002
8	10-carboxymethyl-9-acridanoneIBA 01/2014 - 01/2000
7	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2001
4	Pharmaceutical PreparationsIBA 11/2020 - 09/2000
4	Interferon InducersIBA 01/2015 - 01/2010
3	Immunologic Factors (Immunomodulators)IBA 01/2013 - 01/2003
2	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 04/2001
2	AntigensIBA 01/2020 - 12/2004
2	Meglumine FDA Link 01/2014 - 01/2013
2	TP 7IBA 09/2009 - 01/2008
2	Messenger RNA (mRNA)IBA 01/2003 - 11/2002
1	Biological ProductsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020
1	Interferon beta-1a FDA Link 01/2015
1	Phosphates (Orthophosphate)IBA 01/2015
1	Interferon-betaIBA 01/2015
1	AntibodiesIBA 01/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	Keratin-17 (Keratin 17)IBA 12/2004
1	AcridinesIBA 01/2004
1	Antiparasitic Agents (Antiparasitics)IBA 01/2004
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2003
1	Interferon-alpha (Interferon Alfa)IBA 04/2001
1	larifanIBA 02/2001
1	Tilorone (Tilorone Hydrochloride)IBA 02/2001
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 01/2001
1	poludanIBA 01/2000

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2000
1	Patient Admission (Patient Admissions) 01/2022
1	Length of Stay 01/2021
1	Local Anesthesia 01/2019
1	Immunomodulation 01/2010
1	Aftercare (After-Treatment) 11/2003
1	Immunotherapy 04/2001